Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered anti-TGF-β antibodies and antigen-binding fragments

Engineered anti-TGF-β antibodies and antigen-binding fragments

US Patent 10730936 · Granted Aug 4, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fc containing polypeptides with altered glycosylation and reduced effector funct2025
Fc containing polypeptides with altered glycosylation and reduced effector funct2025
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2025
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Anti-alpha beta TCR binding polypeptides with reduced fragmentation2025
Parathyroid hormone variants2025
Tumor-specific cleavable linkers2025
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of 2025
Oligosaccharide-protein conjugates2025
Anti-CHIKV antibodies and uses thereof2025